Electromagnetic Nanomedicines for Combinational Cancer Immunotherapy

Jingchao Li, Yu Luo*, Kanyi Pu*

*Corresponding author for this work

Research output: Contribution to journalReview articlepeer-review

176 Citations (Scopus)

Abstract

Immunotherapy that harnesses the power of the immune system to eliminate malignant cells has offered an effective approach for cancer treatment. However, limited patient response rates and potential immune-related adverse events exist as two major issues for cancer immunotherapy. In parallel, a variety of electromagnetic nanomaterials that generate heat and/or reactive oxygen species triggered by electromagnetic energy have been applied for magnetic hyperthermia therapy, sonodynamic therapy, photothermal therapy, photodynamic therapy, and radiotherapy, which have the ability to induce immunogenic cell death. This review summarizes the recent development of electromagnetic nanomedicines in combinational cancer immunotherapy. The mechanisms of electromagnetic nanomedicines in reprogramming the immunosuppressive tumor microenvironment and sensitizing tumors for cancer immunotherapy are highlighted. Furthermore, potential challenges and perspectives of electromagnetic nanomedicines for combinational cancer immunotherapy are discussed.

Original languageEnglish
Pages (from-to)12682-12705
Number of pages24
JournalAngewandte Chemie - International Edition
Volume60
Issue number23
DOIs
Publication statusPublished - Jun 1 2021
Externally publishedYes

Bibliographical note

Publisher Copyright:
© 2020 Wiley-VCH GmbH

ASJC Scopus Subject Areas

  • Catalysis
  • General Chemistry

Keywords

  • cancer therapy
  • electromagnetic energy
  • immunogenic cell death
  • immunotherapy
  • nanomedicine

Fingerprint

Dive into the research topics of 'Electromagnetic Nanomedicines for Combinational Cancer Immunotherapy'. Together they form a unique fingerprint.

Cite this